Form 4 for PALI PALISADE BIO, INC.
Accepted 2024-06-12 00:00:00 ET · period of report 2024-06-11 · accession 0001493152-24-023614 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-12 | 2024-06-11 | PALI | Wei Binxian | Dir | M - OptEx | $0.00 | +465 | 467 | +23,250% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Comon Stock, par value $0.01 | 2024-06-11 | M | A | 465 | $0.00 | 467 | D | — | — | (F1) Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023. |